Endra Life Sciences Stock Performance
| NDRA Stock | USD 5.71 0.34 5.62% |
The firm shows a Beta (market volatility) of 0.25, which means not very significant fluctuations relative to the market. As returns on the market increase, ENDRA Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding ENDRA Life is expected to be smaller as well. At this point, ENDRA Life Sciences has a negative expected return of -0.49%. Please make sure to confirm ENDRA Life's skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if ENDRA Life Sciences performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ENDRA Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (5.62) | Five Day Return 11.52 | Year To Date Return (99.79) | Ten Year Return (100.00) | All Time Return (100.00) |
Last Split Factor 1:35 | Last Split Date 2024-11-07 |
1 | Acquisition by Francois Michelon of 713132 shares of ENDRA Life subject to Rule 16b-3 | 10/11/2024 |
2 | ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany | 10/22/2024 |
3 | ENDRA Life Sciences Further Strengthens TAEUS Platform Intellectual Property with Issuance of 17th European Patent | 11/06/2024 |
4 | ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update | 11/15/2024 |
5 | ENDRA Life Sciences regains compliance with Nasdaqs listing rule | 11/22/2024 |
| Begin Period Cash Flow | 4.9 M | |
| Free Cash Flow | -9.6 M |
ENDRA |
ENDRA Life Relative Risk vs. Return Landscape
If you would invest 1,218 in ENDRA Life Sciences on September 1, 2024 and sell it today you would lose (647.00) from holding ENDRA Life Sciences or give up 53.12% of portfolio value over 90 days. ENDRA Life Sciences is currently does not generate positive expected returns and assumes 13.6682% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than ENDRA, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ENDRA Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ENDRA Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ENDRA Life Sciences, and traders can use it to determine the average amount a ENDRA Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.036
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NDRA |
Estimated Market Risk
| 13.67 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.49 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ENDRA Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ENDRA Life by adding ENDRA Life to a well-diversified portfolio.
ENDRA Life Fundamentals Growth
ENDRA Stock prices reflect investors' perceptions of the future prospects and financial health of ENDRA Life, and ENDRA Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ENDRA Stock performance.
| Return On Equity | -1.2 | ||||
| Return On Asset | -0.61 | ||||
| Current Valuation | (1.26 M) | ||||
| Shares Outstanding | 536.91 K | ||||
| Price To Earning | (0.93) X | ||||
| Price To Book | 0.49 X | ||||
| EBITDA | (9.78 M) | ||||
| Net Income | (10.06 M) | ||||
| Cash And Equivalents | 11.28 M | ||||
| Cash Per Share | 0.18 X | ||||
| Total Debt | 394.4 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 9.64 X | ||||
| Book Value Per Share | 27.23 X | ||||
| Cash Flow From Operations | (9.55 M) | ||||
| Earnings Per Share | (2,967) X | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 6.75 M | ||||
| Retained Earnings | (91.93 M) | ||||
| Working Capital | 2.13 M | ||||
| Current Asset | 1.27 M | ||||
| Current Liabilities | 619.6 K | ||||
About ENDRA Life Performance
By analyzing ENDRA Life's fundamental ratios, stakeholders can gain valuable insights into ENDRA Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ENDRA Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ENDRA Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 3.7 K | 3.9 K | |
| Return On Tangible Assets | (1.49) | (1.56) | |
| Return On Capital Employed | (1.80) | (1.89) | |
| Return On Assets | (1.49) | (1.56) | |
| Return On Equity | (1.78) | (1.87) |
Things to note about ENDRA Life Sciences performance evaluation
Checking the ongoing alerts about ENDRA Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ENDRA Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ENDRA Life Sciences generated a negative expected return over the last 90 days | |
| ENDRA Life Sciences has high historical volatility and very poor performance | |
| ENDRA Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (10.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ENDRA Life Sciences currently holds about 11.28 M in cash with (9.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. | |
| ENDRA Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from seekingalpha.com: ENDRA Life Sciences regains compliance with Nasdaqs listing rule |
- Analyzing ENDRA Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ENDRA Life's stock is overvalued or undervalued compared to its peers.
- Examining ENDRA Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ENDRA Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ENDRA Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ENDRA Life's stock. These opinions can provide insight into ENDRA Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ENDRA Stock analysis
When running ENDRA Life's price analysis, check to measure ENDRA Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ENDRA Life is operating at the current time. Most of ENDRA Life's value examination focuses on studying past and present price action to predict the probability of ENDRA Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ENDRA Life's price. Additionally, you may evaluate how the addition of ENDRA Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |